Results 251 to 260 of about 1,324,041 (317)

Opioid Use Disorders: Perioperative Management of a Special Population

, 2018
E. Nalan Ward, Aurora N. Quaye, Timothy E. Wilens   +2 more
openalex   +1 more source

A meta‐analytic review of the relationship between racial discrimination and alcohol and other drug use outcomes in minoritised racial/ethnic groups

Addiction, EarlyView.
Abstract Aims To measure the associations between racial discrimination and distinct alcohol and other drug use outcomes in minoritised racial/ethnic groups and to explore the moderating roles of demographic and methodological characteristics. Methods Quantitative studies including racial discrimination as an exposure (both binary and continuous), an ...
Evie Gates, Matthew Cant, Rebecca Elliott, Patricia Irizar, Christopher J. Armitage   +4 more
wiley   +1 more source

Using narrative and informational messages to improve correctional professionals' attitudes toward medications for opioid use disorder. [PDF]

Health Justice
Harrell-Webber A, Zhao X, Horoszko UA, Murphy A, Smith L, Taxman FS.   +5 more
europepmc   +1 more source

Alcohol and drug use and attainment of pregnancy preferences in the southwestern United States: A longitudinal cohort study

Addiction, EarlyView.
Abstract Aims Addressing design and measurement limitations of prior studies, we examined whether individuals who use alcohol or drugs are less likely to attain their pregnancy preferences over one year. Design Longitudinal cohort study. Setting Five southwestern US states.
Sarah Raifman, Sarah C. M. Roberts, Corinne H. Rocca   +2 more
wiley   +1 more source

A Pooled Sample Study of Opioid Use Disorder Treatment Wait Time Among a Pregnant Population in New York. [PDF]

Epidemiologia (Basel)
Nkemjika S, Begum G, Yoade B, Vyas V, Onyeaka H, Olatunji O, Olayinka O, Jordan A.   +7 more
europepmc   +1 more source

Unpacking the link between substance use disorders and 30‐day unplanned readmission

Addiction, EarlyView.
Abstract Background and Aims Given the more than twofold increase in the prevalence of substance use disorders in the United States in the past decade, more hospital inpatients can be expected to carry substance use disorder diagnoses, necessitating evaluation of potential links to 30‐day unplanned readmissions, a marker of quality of care.
Allison D. Rosen, Sae Takada, Catherine Juillard, Yulsi L. Fernandez Montero, Amy M. Richards, Serge Ngekeng, Steven J. Shoptaw, Michelle A. Bholat   +7 more
wiley   +1 more source

Effectiveness of Washington State's hub and spoke model to improve opioid use disorder outcomes. [PDF]

Health Aff Sch
Reif S, Stewart MT, Daily SM, Panas L, Ritter GA, Brolin MF, Lee MT, Wicks JJ.   +7 more
europepmc   +1 more source

A Dissemination and Implementation Science Approach to the Epidemic of Opioid Use Disorder in the United States

, 2018
Stephanie M. Mathis, Nicholas E. Hagemeier, Angela Hagaman, John Dreyzehner, Robert P. Pack   +4 more
openalex   +2 more sources

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

Access to medication treatment for opioid use disorder in fee-for-service medicare. [PDF]

Health Aff Sch
Taylor EA, Cantor J, Lai J, Agniel D, Simon KI, Stein BD.   +5 more
europepmc   +1 more source